Product Details for NDA 019012
MOTRIN IB (IBUPROFEN)
200MG
Marketing Status: Over-the-counter
200MG
Marketing Status: Discontinued
200MG
Marketing Status: Discontinued
200MG
Marketing Status: Discontinued
200MG
Marketing Status: Over-the-counter
Active Ingredient: IBUPROFEN
Proprietary Name: MOTRIN IB
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N019012
Product Number: 003
Approval Date: Dec 17, 1990
Applicant Holder Full Name: JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIV
Marketing Status: Over-the-counter
Patent and Exclusivity Information
MOTRIN MIGRAINE PAIN (IBUPROFEN)
Proprietary Name: MOTRIN IB
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N019012
Product Number: 003
Approval Date: Dec 17, 1990
Applicant Holder Full Name: JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIV
Marketing Status: Over-the-counter
Patent and Exclusivity Information
200MG
Marketing Status: Discontinued
Active Ingredient: IBUPROFEN
Proprietary Name: MOTRIN MIGRAINE PAIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019012
Product Number: 004
Approval Date: Feb 25, 2000
Applicant Holder Full Name: JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
NUPRIN (IBUPROFEN)
Proprietary Name: MOTRIN MIGRAINE PAIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019012
Product Number: 004
Approval Date: Feb 25, 2000
Applicant Holder Full Name: JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
200MG
Marketing Status: Discontinued
Active Ingredient: IBUPROFEN
Proprietary Name: NUPRIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019012
Product Number: 001
Approval Date: May 18, 1984
Applicant Holder Full Name: JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
NUPRIN (IBUPROFEN)
Proprietary Name: NUPRIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019012
Product Number: 001
Approval Date: May 18, 1984
Applicant Holder Full Name: JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
200MG
Marketing Status: Discontinued
Active Ingredient: IBUPROFEN
Proprietary Name: NUPRIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019012
Product Number: 002
Approval Date: Jul 29, 1987
Applicant Holder Full Name: JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: NUPRIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019012
Product Number: 002
Approval Date: Jul 29, 1987
Applicant Holder Full Name: JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIV
Marketing Status: Discontinued
Patent and Exclusivity Information